---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-137135"
form_type: "8-K"
ticker: "HURA"
cik: "0001498382"
company_name: "TuHURA Biosciences, Inc./NV"
filed_at: "2025-06-06T23:59:59+00:00"
generated_at: "2026-05-19T18:19:11.399266+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# TuHURA raises $12.6M in private placement, $3M from warrants, tied to Phase 3 & merger milestones

## Summary
- Total offering $12.6M (4.76M shares + warrants at $2.65/unit). Initial closing $2.23M.
- $9M purchased in four tranches tied to milestones: FDA partial clinical hold lift, Phase 3 start, Kineta merger close.
- Remaining $3.7M due by Dec 31, 2025. Also received $3.0M from Feb 2025 warrant exercise.
- Proceeds to fund Kineta merger closing, Phase 3 trial of IFx-2.0, and advancement of KVA12123 to Phase 2.
- Warrants exercisable at $3.3125, 5-year term, subject to authorized share increase.

## SEC filing metadata
- accession: 0001193125-25-137135
- form_type: 8-K
- ticker: HURA
- cik: 0001498382
- company_name: TuHURA Biosciences, Inc./NV
- filed_at: 2025-06-06T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 1.01, 3.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1498382/000119312525137135/0001193125-25-137135-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1498382/000119312525137135/d864561d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-137135
- JSON: https://secwatch.observer/filing/0001193125-25-137135.json
- Plain text: https://secwatch.observer/filing/0001193125-25-137135.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.